Socioeconomic costs of amyotrophic lateral sclerosis according to staging system

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 3-4, 2015, Pages 202-208

  Oh, Juyeon ^a,b   An, Ji Won ^c   Oh, Seong Il ^d   Oh, Ki Wook ^a   Kim, Jung A ^b   Lee, Jeong Seop ^b   Kim, Seung Hyun ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Far East University   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

Amyotrophic lateral sclerosis; Cost of illness; Economic burden; Staging system

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COST OF ILLNESS; DISEASE SEVERITY ASSESSMENT; FEMALE; HEALTH CARE COST; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PRIORITY JOURNAL; PRODUCTIVITY; SOCIOECONOMICS; AGED; ANALYSIS OF VARIANCE; CAREGIVER; CROSS-SECTIONAL STUDY; ECONOMICS; EPIDEMIOLOGY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SOCIAL WORK; SOUTH KOREA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; CAREGIVERS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; SOCIAL WORK; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84928968802     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.999791     Document Type: Article

References (23)

1. Bae J , Hong Y , Baek W , Sohn E, Cho J, Kim B, et al. C urrent Status of the Diagnosis and Management of Amyotrophic Lateral Sclerosis in Korea: A Multi-Center Cross-Sectional Study. J Clin Neurol. 2012 ; 8 : 293-300
2. Mehal JM , Holman RC , Schonberger LB, Sejvar JJ. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009. Amyotroph Lateral Scler Frontotemporal Degener. 2013 ; 14 : 346-52
3. Miller R G , Jackson C E, Kasarskis E J, England J D , Forshew D , Johnston W , et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis. Drug, nutritional, and respiratory therapies (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009 ; 73 : 1218-26
4. Larkindale J , Yang W , Hogan P F , Simon C J, Zhang Y , Jain A , et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve. 2014 ; 49 : 431-8
5. Schepelmann K , Winter Y , Spottke AE , Claus D , Grothe C , Schröder R , et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010 ; 257 : 15-23
6. López-Bastida J, Perestelo-Perez L, Monton-Alvarez F , Serrano-Aguilar P , Alfonso-Sanchez JL. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Lateral Scler. 2009 ; 10 : 237-43
7. van der Steen I , van den Berg J -P, Buskens E , Lindeman E , van den Berg LH. The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler. 2009 ; 10 : 27-34
8. Policies (Internet). Sejong: Korea Ministry of Health and Welfare; (date unknown; cited 2013 Dec 31). Available from: http://english.mw.go.kr/.
9. OECD. Health at a Glance 2013: OECD Indicators (Internet). OECD Publishing ; 2013. Available from: http://dx.doi. org/10.1787/health-glance-2013-en.
10. Roche J C, Ricardo Rojas-Garcia, Scott K M , Scotton W , Ellis CE , Burman R , et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012 ; 135 : 847-52
11. Brooks BR , Miller RG , Swash M , Munsat T L. E l Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 ; 1 : 293-9
12. Kim H, Park K, Koh S , Lee S. Korean version of amyotrophic lateral sclerosis functional rating scale-revised: A pilot study on the reliability and validity. J Korean Neurol Assoc. 2007 ; 25 : 149-54
13. Rice D. Estimating the cost of illness. A m J Public Health. 1967 ; 57 : 424-40
14. Mok SA , Cho MO. U tilization of alternative complementary remedies of stroke patients. J Korean Acad Adult Nurs. 2004 ; 16 : 432-41
15. Wage and working hours (Internet). S ejong: Ministry of Employment and Labor; (date unknown; cited 2013 Dec 2). Available from: http://www.moel.go.kr/.
16. Average Foreign Exchange Rate (Internet). S eoul: Korea Exchange Bank; (date unknown; cited 2014 Jan 5). Available from: http://www.keb.co.kr/.
17. Xu K, Evans DB , Kawabata K, Zeramdini R , Klavus J, Murray CJL. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003 ; 362 : 111-7
18. Wasner M , Klier H, Borasio GD. T he use of alternative medicine by patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001 ; 191 : 151-4
19. Yun MH , Choi-Kwon S. Q uality of life and the factors related to family caregivers caring for those with amyotrophic lateral sclerosis. Perspect Nurs Sci. 2011 ; 8 : 62-72
20. Chio A , Gauthier A , Vignola A , Calvo A. C aregiver time use in ALS. Neurology. 2006 ; 67 : 902-4
21. Kim M , Shin H , Min Y. C orrelation between Severe ALS Patient-Caregiver Couples Characteristics and Caregivers Health Related Quality of Life. J Korean Acad Nurs. 2011 ; 41 : 354-63
22. Kim H Y , Kim H , Oh K W, Oh S I , Koh S H , Baik W. B iological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigatorinitiated trial and in vivo study. Stem Cells. 2014 ; 32 : 2724-31
23. Kim HY , Moon C, Kim KS , Oh KW, Oh S-i , Kim J. R ecombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility. J Clin Neurol. 2014 ; 10 : 342-7 .